Summary
University of Michigan (UM) is a research university that offers educational and research services. The university offers graduate, undergraduate and post-doctoral levels programs in various disciplines. Its graduate schools and colleges include Rackham school of graduate studies, architecture, urban planning, education, engineering, information, kinesiology, law, medicine, music, theatre, dance, natural resources, environment, nursing and pharmacy. The university offers undergraduate studies in the areas of literature, science, architecture, urban, planning, art, design, business, education nursing, pharmacy and public policy. UM is headquartered in Ann Arbor, Michigan, the US.
University of Michigan - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
University of Michigan, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Michigan, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of Michigan, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Michigan, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of Michigan, Medical Devices Deals, 2010 to YTD 2016 10
University of Michigan, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
University of Michigan, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
ViewPoint Therapeutics Raises USD4 Million in Series A Financing 13
Confo Therapeutics Raises USD7.3 Million Financing 14
Millendo Therapeutics Raises USD62 Million in Series B Venture Financing 16
Akadeum Life Sciences Raises USD1 Million in Financing Round 18
Partnerships 19
AstraZeneca and MedImmune Enter into Agreement with University of Michigan and Eli Lilly 19
IFM Therapeutics to Enter into Research Agreement with University of Michigan 21
University of Michigan Enters Into Joint Venture Agreement With International Genomics Consortium 22
University Of Michigan Medical School Enters Into Research Agreement With MedImmune 23
Galectin Therapeutics Enters Into Research Agreement With University of Michigan 24
University of Michigan Medical School Forms Joint Venture With PUHSC 25
Licensing Agreements 26
Kura Oncology Amends its Licensing Agreement with University of Michigan 26
Diapin Therapeutics Enters into Licensing Agreement with University of Michigan 27
Ascentage Pharma Amends Licensing Agreement with Regents of the University of Michigan 28
Wilson Therapeutics Enters into Licensing Agreement with University of Michigan 29
Omni Sciences Enters Into Licensing Agreement With University of Michigan 30
NanoBio Enters Into Licensing Agreement With University Of Michigan 31
Medgenics Enters Into Licensing Agreement With Regents Of The University Of Michigan 32
NeoStem Enters Into Option Licensing Agreement With University of Michigan 33
Asset Transactions 34
PDL BioPharma Acquires 75% of Royalty Interest in Cerdelga from University of Michigan for USD65.6 Million 34
University of Michigan - Key Competitors 36
Key Employees 37
Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
University of Michigan, Pharmaceuticals & Healthcare, Key Facts 1
University of Michigan, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Michigan, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of Michigan, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Michigan, Deals By Therapy Area, 2010 to YTD 2016 8
University of Michigan, Medical Devices Deals, 2010 to YTD 2016 10
University of Michigan, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
ViewPoint Therapeutics Raises USD4 Million in Series A Financing 13
Confo Therapeutics Raises USD7.3 Million Financing 14
Millendo Therapeutics Raises USD62 Million in Series B Venture Financing 16
Akadeum Life Sciences Raises USD1 Million in Financing Round 18
AstraZeneca and MedImmune Enter into Agreement with University of Michigan and Eli Lilly 19
IFM Therapeutics to Enter into Research Agreement with University of Michigan 21
University of Michigan Enters Into Joint Venture Agreement With International Genomics Consortium 22
University Of Michigan Medical School Enters Into Research Agreement With MedImmune 23
Galectin Therapeutics Enters Into Research Agreement With University of Michigan 24
University of Michigan Medical School Forms Joint Venture With PUHSC 25
Kura Oncology Amends its Licensing Agreement with University of Michigan 26
Diapin Therapeutics Enters into Licensing Agreement with University of Michigan 27
Ascentage Pharma Amends Licensing Agreement with Regents of the University of Michigan 28
Wilson Therapeutics Enters into Licensing Agreement with University of Michigan 29
Omni Sciences Enters Into Licensing Agreement With University of Michigan 30
NanoBio Enters Into Licensing Agreement With University Of Michigan 31
Medgenics Enters Into Licensing Agreement With Regents Of The University Of Michigan 32
NeoStem Enters Into Option Licensing Agreement With University of Michigan 33
PDL BioPharma Acquires 75% of Royalty Interest in Cerdelga from University of Michigan for USD65.6 Million 34
University of Michigan, Key Competitors 36
University of Michigan, Key Employees 37
University of Michigan, Subsidiaries 38
List of Figures
University of Michigan, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of Michigan, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of Michigan, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of Michigan, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of Michigan, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Michigan, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
University of Michigan, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Michigan, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of Michigan, Medical Devices Deals, 2010 to YTD 2016 10
